Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Open Label”

40,490 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 40,490 results

Early research (Phase 1)Study completedNCT06170723
What this trial is testing

Assess the Effects of Itraconazole, Food, and pH on the Drug Levels of BMS-986368 in Healthy Participants

Who this might be right for
Healthy Participants
Celgene 32
Large-scale testing (Phase 3)Active Not RecruitingNCT05314023
What this trial is testing

Immunogenicity and Safety of V503 in Chinese Males 9 Through 19 Years Old (V503-053)

Who this might be right for
Genital Warts
Merck Sharp & Dohme LLC 1,590
Testing effectiveness (Phase 2)Study completedNCT03625323
What this trial is testing

Combination Study With Soluble LAG-3 Fusion Protein Eftilagimod Alpha (IMP321) and Pembrolizumab in Patients With Previously Untreated Unresectable or Metastatic NSCLC, or Recurrent PD-X Refractory NSCLC or With Recurrent or Metastatic HNSCC

Who this might be right for
NSCLCHNSCC
Immutep S.A.S. 187
Large-scale testing (Phase 3)Looking for participantsNCT07393282
What this trial is testing

Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)

Who this might be right for
High Risk Smoldering Multiple Myeloma (HR-SMM)
Regeneron Pharmaceuticals 270
Testing effectiveness (Phase 2)Study completedNCT00150982
What this trial is testing

Alefacept Mechanism of Action in Psoriasis

Who this might be right for
Psoriasis
University of Medicine and Dentistry of New Jersey 9
Early research (Phase 1)Study completedNCT01153659
What this trial is testing

Evaluate the Effect on 24-hour, Intragastric pH of RAB ER 50-mg Capsules Compared With Esomeprazole (Nexium) 40 mg Capsules and Rabeprazole (Aciphex) 20-mg Tablets

Who this might be right for
Healthy
Eisai Inc. 90
Large-scale testing (Phase 3)Study completedNCT03251859
What this trial is testing

Effectiveness of Lower Maintenance Dose of Ticagrelor Early After Myocardial Infarction (ELECTRA) Pilot Study

Who this might be right for
Myocardial Infarction
Collegium Medicum w Bydgoszczy 52
Early research (Phase 1)Study completedNCT03934359
What this trial is testing

Evaluate the Safety, Tolerability of DN1508052-01 in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Shanghai De Novo Pharmatech Co., Ltd. 19
Early research (Phase 1)Study completedNCT02875080
What this trial is testing

Evaluation Study of the Bioavailability of Brexpiprazole Orally Disintegrating Tablets in Healthy Male Subjects

Who this might be right for
Healthy Adult Male
Otsuka Pharmaceutical Co., Ltd. 18
Early research (Phase 1)Study completedNCT00840879
What this trial is testing

Meloxicam 15 mg Tablets Under Non-Fasting Conditions

Who this might be right for
Healthy
Teva Pharmaceuticals USA 28
Early research (Phase 1)UnknownNCT04448379
What this trial is testing

Efficacy and Safety of JMT101 Combined With Afatinib (or Osimertinib) in Patients With Non-Small Cell Lung Cancer

Who this might be right for
Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Shanghai JMT-Bio Inc. 48
Large-scale testing (Phase 3)Ended earlyNCT00865579
What this trial is testing

Open-Label Trial to Determine the Long-Term Safety of Safinamide in Parkinson's Disease Patients

Who this might be right for
Parkinson's Disease
Newron Pharmaceuticals SPA 964
Early research (Phase 1)Study completedNCT00938262
What this trial is testing

Evaluate the Effect of Ketoconazole and Rifampicin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 24
Large-scale testing (Phase 3)Active Not RecruitingNCT05063162
What this trial is testing

Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease (MOGAD)

Who this might be right for
Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD)
UCB Biopharma SRL 113
Large-scale testing (Phase 3)Study completedNCT01063062
What this trial is testing

A Study With Tocilizumab [RoActemra/Actemra] Monotherapy or in Combination With Methotrexate in Patients With Rheumatoid Arthritis (PICTURE)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 107
Early research (Phase 1)Looking for participantsNCT07688746
What this trial is testing

Neonatal White Matter Injury Trial (WRAP)

Who this might be right for
White Matter InjuryBrain Injury, Fetus and NeonateNeonatal Brain Injury+2 more
Bridget LaMonica Ostrem, M.D., Ph.D. 24
Not applicableStudy completedNCT00776646
What this trial is testing

Bioequivalence Study of Hydrochlorothiazide 50mg Tablets Under Fasting Conditions

Who this might be right for
Healthy
Ranbaxy Laboratories Limited 36
Not applicableNot Yet RecruitingNCT07618546
What this trial is testing

A Multicenter, Randomized, Open-label, Controlled Study of HAIC Combined With Camrelizumab and Apatinib Mesylate for Perioperative Treatment of Resectable Hepatocellular Carcinoma With High-risk Recurrence Factors

Who this might be right for
HCC - Hepatocellular Carcinoma
Henan Cancer Hospital 208
Early research (Phase 1)Study completedNCT02227888
What this trial is testing

PK Study of N91115 in Cystic Fibrosis Patients

Who this might be right for
Cystic Fibrosis
Nivalis Therapeutics, Inc. 6
Early research (Phase 1)Study completedNCT06092788
What this trial is testing

Safety, Pharmacokinetics (PK) and Relative Bioavailability of NTP42:KVA4 as a Solid Oral Dose

Who this might be right for
Healthy
ATXA Therapeutics Limited 13
Next Page